de la Fuente, M.; Grazu, V., Nanobiotechnology: Inorganic Nanoparticles vs Organic Nanoparticles., Frontiers in Nanoscience,
Innocenti F., Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response, 2, Humana Press, 2009
Martin M.Z., Concepts in Pharmacogenomics, ASHP, 2010
Steinitz, M. (Ed.), Human monoclonal antibodies, Humana Press, 2014
Wood, C.R., Antibody Drug Discovery, World scientist, 2011
Bibliografía Complementaria
Dobrovolskaia, M.A., McNeil S.E., Handbook of immunological properties of engineered nanomaterials, World scientist, 2016
Feng, T., Zhao, Y.i, Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy, Springer, 2017
Jain, K.K, The handbook of nanomedicine, 3, Springer, 2017
Meibohm, B., Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development, Wiley-VCH, 2007
Sabater Tobella, J., Sabater Sales G., Medicina personalizada posgenómica: conceptos prácticos para clínicos, Elsevier, 2010
Selvan, T, Narayanan, K, Introduction to Nanotheranostics, Springer, 2016
Zivic, F. (Ed), Biomaterials in clinical practice, Springer, 2018
Universidade de Vigo
|
Rectorado |
Campus Universitario |
C.P. 36.310 Vigo (Pontevedra) |
España |
Tlf: +34 986 812 000
de la Fuente, M.; Grazu, V., Nanobiotechnology: Inorganic Nanoparticles vs Organic Nanoparticles., Frontiers in Nanoscience,